Cavu Management, LP, 10% Owner, Director at COGNITION THERAPEUTICS INC (CGTX), bought 1,500,000 shares at $1.20 ($1.8M) on 2022-11-15, disclosed to the SEC on 2022-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 174,700 | $210K | 11.6% |
| 2 | $1.20 | 184,270 | $221K | 12.3% |
| 3 | $1.20 | 1,141,030 | $1.4M | 76.1% |
| Total | $1.20 avg | 1,500,000 | $1.8M | 100% |
| Filing → |
| INAB | BUY | 2022-08-18 | $170K | — | Filing → |